| Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus B Korber, WM Fischer, S Gnanakaran, H Yoon, J Theiler, W Abfalterer, ... Cell 182 (4), 812-827. e19, 2020 | 4271 | 2020 |
| Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes JE Schmitz, MJ Kuroda, S Santra, VG Sasseville, MA Simon, MA Lifton, ... Science 283 (5403), 857-860, 1999 | 2860 | 1999 |
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection BF Keele, EE Giorgi, JF Salazar-Gonzalez, JM Decker, KT Pham, ... Proceedings of the National Academy of Sciences 105 (21), 7552-7557, 2008 | 2322 | 2008 |
| Immune-correlates analysis of an HIV-1 vaccine efficacy trial BF Haynes, PB Gilbert, MJ McElrath, S Zolla-Pazner, GD Tomaras, ... New England Journal of Medicine 366 (14), 1275-1286, 2012 | 2104 | 2012 |
| Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity JW Shiver, TM Fu, L Chen, DR Casimiro, ME Davies, RK Evans, ... Nature 415 (6869), 331-335, 2002 | 1506 | 2002 |
| Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine RR Amara, F Villinger, JD Altman, SL Lydy, SP O'Neil, SI Staprans, ... Science 292 (5514), 69-74, 2001 | 1436 | 2001 |
| Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing … M Li, F Gao, JR Mascola, L Stamatatos, VR Polonis, M Koutsoukos, ... Journal of virology 79 (16), 10108-10125, 2005 | 1268 | 2005 |
| Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus HX Liao, R Lynch, T Zhou, F Gao, SM Alam, SD Boyd, AZ Fire, KM Roskin, ... Nature 496 (7446), 469-476, 2013 | 1122 | 2013 |
| Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination DH Barouch, S Santra, JE Schmitz, MJ Kuroda, TM Fu, W Wagner, ... Science 290 (5491), 486-492, 2000 | 1096 | 2000 |
| Studies in subjects with long-term nonprogressive human immunodeficiency virus infection G Pantaleo, S Menzo, M Vaccarezza, C Graziosi, OJ Cohen, JF Demarest, ... New England Journal of Medicine 332 (4), 209-216, 1995 | 961 | 1995 |
| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 954 | 2022 |
| Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes DH Barouch, J Kunstman, MJ Kuroda, JE Schmitz, S Santra, FW Peyerl, ... Nature 415 (6869), 335-339, 2002 | 872 | 2002 |
| Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies … GD Tomaras, NL Yates, P Liu, L Qin, GG Fouda, LL Chavez, AC Decamp, ... Journal of virology 82 (24), 12449-12463, 2008 | 828 | 2008 |
| Evaluating neutralizing antibodies against HIV, SIV, and SHIV in luciferase reporter gene assays DC Montefiori Current protocols in immunology 64 (1), 12.11. 1-12.11. 17, 2004 | 731 | 2004 |
| Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies MS Seaman, H Janes, N Hawkins, LE Grandpre, C Devoy, A Giri, ... Journal of virology 84 (3), 1439-1452, 2010 | 723 | 2010 |
| Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine SM Hammer, ME Sobieszczyk, H Janes, ST Karuna, MJ Mulligan, ... New England Journal of Medicine 369 (22), 2083-2092, 2013 | 709 | 2013 |
| Measuring HIV neutralization in a luciferase reporter gene assay DC Montefiori HIV protocols, 395-405, 2009 | 619 | 2009 |
| An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants NF Rose, PA Marx, A Luckay, DF Nixon, WJ Moretto, SM Donahoe, ... Cell 106 (5), 539-549, 2001 | 571 | 2001 |
| HIV-1 neutralizing antibodies induced by native-like envelope trimers RW Sanders, MJ van Gils, R Derking, D Sok, TJ Ketas, JA Burger, ... Science 349 (6244), aac4223, 2015 | 539 | 2015 |
| A bivalent omicron-containing booster vaccine against Covid-19 S Chalkias, C Harper, K Vrbicky, SR Walsh, B Essink, A Brosz, N McGhee, ... New England Journal of Medicine 387 (14), 1279-1291, 2022 | 538 | 2022 |
